(S)-3-Amino-3-(5-(tert-butyl)-1H-benzo[d]imidazol-2-yl)-2,2-dimethylpropanamide

ID: ALA4456468

Chembl Id: CHEMBL4456468

PubChem CID: 86699080

Max Phase: Preclinical

Molecular Formula: C16H24N4O

Molecular Weight: 288.40

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)c1ccc2[nH]c([C@@H](N)C(C)(C)C(N)=O)nc2c1

Standard InChI:  InChI=1S/C16H24N4O/c1-15(2,3)9-6-7-10-11(8-9)20-13(19-10)12(17)16(4,5)14(18)21/h6-8,12H,17H2,1-5H3,(H2,18,21)(H,19,20)/t12-/m1/s1

Standard InChI Key:  LRVZVLLBGQIXOZ-GFCCVEGCSA-N

Associated Targets(Human)

SCN10A Tclin Sodium channel protein type X alpha subunit (396 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 288.40Molecular Weight (Monoisotopic): 288.1950AlogP: 2.37#Rotatable Bonds: 3
Polar Surface Area: 97.79Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 11.59CX Basic pKa: 7.24CX LogP: 2.22CX LogD: 1.99
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.81Np Likeness Score: -1.01

References

1. Brown AD, Bagal SK, Blackwell P, Blakemore DC, Brown B, Bungay PJ, Corless M, Crawforth J, Fengas D, Fenwick DR, Gray V, Kemp M, Klute W, Malet Sanz L, Miller D, Murata Y, Payne CE, Skerratt S, Stevens EB, Warmus JS..  (2019)  The discovery and optimization of benzimidazoles as selective NaV1.8 blockers for the treatment of pain.,  27  (1): [PMID:30538065] [10.1016/j.bmc.2018.12.002]

Source